Demedicalizing Depression: An Interview with Milutin Kostić
Justin Karter interviews Milutin Kostić on the fundamental flaws in depression research and its neglect of human complexity.
Antiseizure Drug Exposure in Pregnancy Linked to Large Risk of Autism, ADHD, and Intellectual...
Harms are “largely overlooked by psychiatry despite widespread usage,” according to the researchers.
Review Documents Severe Withdrawal Effects of Psychiatric Drugs
Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.
Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients: Interview with Psychiatrist Swapnil Gupta
Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.
Remembering Bhargavi Davar: A Global Leader in the Struggle for Human Rights
Bhargavi Davar was a global leader in the struggle for human rights, with her work as a psychiatric survivor activist simply one aspect of that work.
Antidepressants No Better Than Placebo for About 85% of People
Researchers can’t predict the 15% who benefit from antidepressants, and the other 85% are unnecessarily exposed to the harms of the drugs.
Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
Long-term Outcomes Better for Those Who Stop Taking Antipsychotics
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.
Placebo Effect—Not Antidepressants—Responsible for Depression Improvement
In adolescent depression treatment, those who received a placebo but thought they received Prozac improved more than those who received the drug and knew it.
When Medication Changes More Than Symptoms: Antipsychotics’ Effect on Identity
Recent research reveals how antipsychotic medications can significantly impact users' identity and self-image, challenging existing clinical approaches.
Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.
Wunderink: Antipsychotics Can Be Tapered Safely Without Increasing Relapse Risk
Tapering antipsychotics slowly and with supported decision-making may improve care for patients with psychosis.
Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?
Research sheds light on the impact of antidepressants on sexual dysfunction, emphasizing the need for patient-physician communication.
Robin Williams On Antidepressant at Time of Suicide
Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...
Newborn Babies Go Through Antidepressant Withdrawal
A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.
Long-Term Benzo Use Linked to Increased Disability
Despite guidance that the drugs should only be used short-term, about a third of patients indicated long-term benzo use.
Hyperbolic Tapering off Antidepressants Limits Withdrawal
New research by Jim van Os and Peter Groot finds that using hyperbolic tapering to discontinue antidepressants reduces withdrawal effects.
Involuntary Hospitalization Increases Risk of Suicide, Study Finds
New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.
Antipsychotics Increase Risk of Dementia; New Research Illuminates Why
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.
Antipsychotics Lead to Worse Outcomes in First-Episode Psychosis
Those who did not get antipsychotics in the first month were almost twice as likely to be in recovery after five years.
Case Studies Reveal Patient Empowerment Through Tapering Antipsychotics
A new study shows how different patients respond to tapering antipsychotic medication under expert guidance, highlighting personal empowerment and the complexities of withdrawal.
Adding Antipsychotics Worsens Outcomes in Psychotic Depression
Outcomes were worse for all, with young people on combination therapy twice as likely to experience rehospitalization or death by suicide than those on antidepressants alone.
How Does the Soteria House Heal?
The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.
SSRI Withdrawal has Social, Cognitive, and Emotional Consequences
New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.
Stop Using Antidepressants Except for “the Most Severe Depression,” Experts Say
Experts advocate limiting antidepressant use to only the most severe cases of depression, emphasizing the need for social and psychological interventions.